INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

74,196 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
PA
Parison AmySVP, Chief Financial Officer
EDITEditas Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$1,376
453 sh
Sep 3, 2026Sep 4, 2026
Page 473 of 1855
← PrevNext →
traded Sep 3, 2026
+1d
SEC Form 4

Evidence

10
TN
Thornberry NancyDirector
DNLIDenali Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$15K
615 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
HY
Holton Adam YChief People Officer
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$47K
673 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Option exercise
M—
10.7K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BH
Baran Elizabeth H.SVP, General Counsel
DKSDICK'S SPORTING GOODS, INC.
Tax withholding
F$9,504
68 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
NY
Naos YaronSr. VP & COO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
56.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
NA
Newcomb George A.Chief Accounting Officer
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$7,903
112 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
KJ
Kim JoyceDirector
QUIKQUICKLOGIC Corp
Option exercise
M—
5,246 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
44.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
CD
Collins John DeNeenCFO and COO
LPSNLIVEPERSON INC
Disposition to issuer
D—
6,260 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$106K
2,477 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
AJ
Argen JohnDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
GM
Grover MatthewDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
SC
Stein CliffordDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BS
Ben Zvi ShmuelDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
8,500 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
MA
Maglione Lawrence A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
TJ
Tjon Karin-JoyceDirector
LPSNLIVEPERSON INC
Disposition to issuer
D—
18.7K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
SN
Stallone NancyDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
WI
Wilson IanEXECUTIVE VICE PRESIDENT
AMCRAmcor plc
Option exercise
M—
5,782 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
LN
Lane NathanDirector
LPSNLIVEPERSON INC
Disposition to issuer
D—
23.4K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
44.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
GM
Grover MatthewDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
SC
Stein CliffordDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
LK
Lefferts KellyEVP, Chief Legal Officer
BLMNBloomin' Brands, Inc.
Option exercise
M—
15.4K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
CA
Correll Todd A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
PJ
Pace Philip JSVP, Chief Accounting Officer
BLMNBloomin' Brands, Inc.
Option exercise
M—
15.4K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
KT
Kempster ThomasDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
SJ
Schwartz Harold JDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
TJ
Tarangelo James J.EVP and CFO
ARMKAramark
Option exercise
M—
8,852 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
PV
Pegueros VanessaDirector
LPSNLIVEPERSON INC
Disposition to issuer
D—
22.7K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
AJ
Argen JohnDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$317K
30.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BD
Bashan DrorDirector, PRESIDENT AND CEO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
320.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
BD
Bashan DrorDirector, PRESIDENT AND CEO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
160.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
MA
Mitchell Uwayne A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
FD
Frieson DonaldDirector
CASYCASEYS GENERAL STORES INC
Grant or award
A—
220 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
FD
Frieson DonaldDirector
CASYCASEYS GENERAL STORES INC
Option exercise
M—
326 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
EC
Elze ChristianDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
17.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
NY
Naos YaronSr. VP & COO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
112.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
EC
Elze ChristianDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
8,500 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence